SCHEMBL30201703

SCHEMBL30201703

O=CC1CCN(c2ccc([C@@H]3CCC(=O)NC3=O)cn2)CC1

nearest known ligand 0.48

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 19/20 0.48
DDB1 Q16531 18/20 0.48
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30851413 1.00 CRBN (0.48) CRBNDDB1POLB
SCHEMBL25143839 1.00 CRBN (0.48) CRBNDDB1POLB
SCHEMBL25143840 1.00 CRBN (0.48) CRBNDDB1POLB
SCHEMBL24670099 1.00 CRBN (0.48) CRBNDDB1POLB
SCHEMBL25074541 0.93 CRBN (0.46) CRBNDDB1POLB
SCHEMBL30201974 0.93 CRBN (0.46) CRBNDDB1POLB
SCHEMBL31470530 0.87 CRBN (0.44) CRBNDDB1POLB
SCHEMBL31109498 0.87 CRBN (0.54) CRBNDDB1POLB
SCHEMBL30851426 0.87 CRBN (0.54) CRBNDDB1POLB
SCHEMBL25502497 0.87 CRBN (0.54) CRBNDDB1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4367118-A1 BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND THERAPEUTIC USE THEREOF Nurix Therapeutics, Inc. (US) 2024-05-15 EP disclosed
WO-2023023255-A1 BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND THERAPEUTIC USE THEREOF NURIX THERAPEUTICS, INC. (US) 2023-02-23 WO disclosed